North Dallas Bank & Trust’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.21M Buy
1,844
+186
+11% +$190K 1.31% 22
2026
Q1
$1.52M Buy
1,658
+40
+2% +$40.6K 1.03% 28
2025
Q4
$1.74M Buy
+1,618
New +$1.55M 1.13% 27

Other funds holding LLY

North Dallas Bank & Trust's LLY Position: Q2 2026 in Review

North Dallas Bank & Trust increased its Eli Lilly (LLY) stake by 11% in Q2 2026, buying an estimated $190K and bringing the position to 1,844 shares worth $2.21M. The position accounts for 1.31% of the portfolio, ranked #22.

North Dallas Bank & Trust first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 2,000 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • North Dallas Bank & Trust held 1,844 shares of Eli Lilly worth $2.21M as of Q2 2026.
  • North Dallas Bank & Trust bought 186 Eli Lilly shares in Q2 2026, an estimated $190K.
  • Eli Lilly made up 1.31% of North Dallas Bank & Trust's portfolio in Q2 2026, its #22 holding.
  • North Dallas Bank & Trust first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 2,000 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on North Dallas Bank & Trust's 13F filing for Q2 2026, filed 13 Jul 2026.